Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Animal or plant cell
Reexamination Certificate
2011-01-18
2011-01-18
Skelding, Zachary (Department: 1644)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Animal or plant cell
C424S093210
Reexamination Certificate
active
07871606
ABSTRACT:
The invention relates to the use of peripheral-blood mononuclear cells that have been stimulated via cascade priming (CAPRI cells) for the purpose of providing an agent for the treatment of cancerous diseases. The CAPRI cells may also be administered in combination with CD3-activated cells.
REFERENCES:
patent: 5217704 (1993-06-01), Johnson et al.
patent: 5766920 (1998-06-01), Babbitt et al.
patent: 5837233 (1998-11-01), Granger
patent: 68925660 (1989-06-01), None
patent: 19814701 (1998-04-01), None
patent: 409655 (1991-01-01), None
patent: WO 9520349 (1995-01-01), None
patent: WO 9520649 (1995-08-01), None
patent: WO 9629394 (1996-09-01), None
patent: WO 9732970 (1997-09-01), None
patent: WO 9950393 (1999-10-01), None
Marzo et al., J Immunol. May 15, 1999;162(10):5838-45.
Gold et al., J Surg Res. Aug. 1995;59(2):279-86.
RWS Group plc, English language translation of Sep. 12, 2000 of PCT/EP99/02225, filed Mar. 31, 1999.
Takayama, T. et al., “Adoptive Immunotherapy to Lower Postsurgical Recurrence Rates of Hepatocellular Carcinoma: A Randomised Trial,” Lancet (2000), vol. 356, n. 9232. pp. 802-807.
Stohl et al., Abstract, “Stimulation of human peripheral blood mononuclear cells with anti-CD3 monoclonal antibody vs. IL2: disparate effects on T cell-dependent B cell differentiation despite similar effects on generation of unrestricted cytolytic activity,” PubMed 1395122, Clin. Immunol. Immunopathol., (1992), 65(1):30-8.
Baxevauis et al., Abstract, “Induction of anti-tumor lymphocytes in cancer patients after brief exposure to supematants from cultures of anti-CD3-stimulated allogeneic lymphocytes,” PubMed 9376269, Br. J. Cancer, (1997) 76(8), pp. 1072-1080.
van Leeuwen et al., “T cell antigen-receptor signal transduction,” Cuff. Opin. Immunol., (1999), 11:242-248.
Sheehy et al., “HL-A LD(lymphocyte defined)typing: a rapid assay with primed lymphocytes,” Science, (1975), 188:1308-1310.
Wank et al., “High risk of squamous cell carcinoma for women with HLA-DQw3,” Nature, (1991), 352:723-725.
Chang, Kenneth J. M.D., et al. “Phase I Clinical Trail of Allogeneic Mixed Lymphocyte Culture (Cytoimplant) Delivered by Endoscopic Ultrasound—Guided Fine-Needle Injection in Patients with Advanced Pancreatic Carcinoma.”CancerMar. 15, 2000, vol. 88, No. 6. pp. 1325-1335.
Andres Alcover et al., Internalization and Intracelluar Fate of TCR-CD3 Complexes, Critical Reviews in Immunology 20:325-346 (2000).
Haiyan Liu et al., On the Dynamics of TCR:CD3 Complex Cell Surface Expression and Downmodulation, Immunity, vol. 13, 665-675, Nov. 2000.
Crowell & Moring LLP
Skelding Zachary
LandOfFree
Use of stimulated peripheral-blood mononuclear cells for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of stimulated peripheral-blood mononuclear cells for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of stimulated peripheral-blood mononuclear cells for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2685405